Roles and practice of living-related lobar lung transplantation

: Living-donor lobar lung transplantation (LDLLT) was first performed in the USA and thereafter it introduced Japan 1998 as an alternative modality to brain-dead donor (BDLT). Although LDLLT procedure employed for rapidly deteriorating patients who were hospitalized mechanically ventilated at time of transplantation, demonstrated better or comparable post-transplant outcomes comparison BDLT. Less injured grafts a significantly shorter graft ischemic possibly contributed lower incidence severe primary dysfunction (PGD) after In standard LDLLT, obtained from two different donors, thus most developed chronic allograft (CLAD) only unilateral graft. This indicates that contralateral unaffected could reserve function development CLAD. our transplant program, CLAD per (14.4%) also BDLT (24.7%). The 1-, 5- 10-year survival rates 90.9%, 75.5% 57.2%, respectively, which equivalent those (92.9%, 73.4% 62.2%). inherent surgical risk living donors should always be considered. experience, living-donor surgery associated with complication rate 12.7%, importantly, all finally returned their previous social lives. Precise functional anatomical size matching between recipient provide favorable pulmonary LDLLT. We recently established multimodal approaches, such native upper lobe-sparing, right-to-left horizontally rotated, segmental, single-lobe order resolve issue mismatch recipient.